Reading list
Selected journal articles
The postmenopausal experiment starts the discussion. The other papers supply the physiology, chemistry and clinical outcomes.
The estrogen experiment and its neighbours
Begin with endogenous estrogen and the postmenopausal rebound. The experiments in older men and young men with experimentally induced hypogonadism examine other hormonal settings.
From the molecule to measured outcomes
The tesamorelin review and non-clinical pharmacology study discuss the analogue's design. The healthy-men experiment examines hormone responses. The cognitive trials in older adults and people with HIV ask about cognitive outcomes. The complete list also includes the glucose trial and the review of adverse effects discussed on the site.
- Endogenous Estrogen Regulates Somatostatin-Induced Rebound GH Secretion in Postmenopausal Women. ↗
- Differential pulsatile secretagogue control of GH secretion in healthy men. ↗
- Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism. ↗
- Tesamorelin: a growth hormone-releasing factor analogue for HIV-associated lipodystrophy ↗
- Non-clinical pharmacology and safety evaluation of TH9507, a human growth hormone-releasing factor analogue. ↗
- Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men ↗
- Effects of growth hormone-releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial ↗
- Effects of Tesamorelin on Neurocognitive Impairment in Persons With HIV and Abdominal Obesity ↗
- Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial ↗
- Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials. ↗